About this trial
Patients with brain injury secondary to stroke, surgery, or trauma frequently suffer from homonymous hemianopia, defined as vision loss in one hemifield secondary to retro- chiasmal lesion. Classic and effective saccadic compensatory training therapies are current aim to reorganize the control of visual information processing and eye movements or, in other words, to induce or improve oculomotor adaptation to visual field loss. Patients learn to intentionally shift their eyes and, thus, their visual field border, into the area corresponding to their blind visual field. This shift brings the visual information from the blind hemifield into the seeing hemifield for further processing. Patients learn, therefore, to efficiently use their eyes "to keep the 'blind side' in sight". Biofeedback training (BT) is the latest and newest technique for oculomotor control training in cases with low vision when using available modules in the new microperimetry instruments. Studies in the literature highlighted positive benefits from using BT in a variety of central vision loss, nystagmus cases, and others.The purpose of this study is to assess systematically the impact of BT in a series of cases with hemianopia and formulate guidelines for further use of this intervention in vision rehabilitation of hemianopia cases in general.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
hemianopia cases previously diagnosed accordingly by microperimetry and other tests as needed
18-90 years old
ability to follow the visual and auditory stimuli and training instructions
Disqualifiers
previous or current treatment for low vision rehabilitation
ocular diseases
other serious clinical conditions not related to the hemianopia physiopathology
both eyes with media opacity that impairs microperimetry testing
Trial design
Parallel
Treatments tested in this trial
Biofeedback training
DeviceThe training of oculomotor functions is done on the biofeedback module of a microperimeter MAIA.
Treatment groups
Trial outcomes
Primary outcomes
Visual Acuity
ETDRS best corrected visual acuity
Fixation stability
As measure by the MAIA microperimeter at the BCEA 63% ellipse area.
Retinal sensitivity
Paracentral (2 central vertical columns) and total average in dB as measured by the MAIA microperimeter.
Reading speed
As measured with the MNRead charts
Secondary outcomes
Stereopsis
As measured with the Frisby stereotest
Contrast Sensitivity
As measured with the F.A.C.T. test at 1m
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University Health Network, Toronto
Lead sponsor
University of Toronto
Collaborator